Psychopharmacol 23, 121
Related products BPC-157/TB-500 GHK-Cu Methylene Blue SLU-PP-332 controlled in-vitro laboratory research conducted by qualified professionals.
Underlying health conditions: Some health conditions, such as gastrointestinal disorders or liver disease, can affect B12 absorption and metabolism, potentially leading to shorter-lasting benefits from B12 injections
The compound distributes preferentially to metabolically active organs, showing highest concentrations in the kidneys and liver, followed by the stomach wall, thymus, spleen, and intestines
In the control group, a total of 108 oocytes cultured post-fertilization, resulting in 40 oocytes (37.13.7)% reaching the cleavage stage, 16 developing into morulas (14.64.3)%, and 9 forming blastocysts (8.12.1)%